Beneficial effects of the Src inhibitor, dasatinib, on breakdown of the blood-retinal barrier
Authors:
- 17 December 2016
- journal article
- research article
- Published by Springer Nature in Archives of Pharmacal Research
- Vol. 40 (2) , 197-203
Abstract
Src kinase signaling is important in the regulation of microvascular barrier function and endothelial hyperpermeability. This study was designed to evaluate the protective effect of dasatinib, a potent Src inhibitor used clinically for the treatment of cancer, against the breakdown of the blood-retinal barrier (BRB) and the retinal vascular leakage caused by vascular endothelial growth factor (VEGF) and diabetes. We examined the effects of dasatinib on VEGF-induced endothelial hyperpermeability and the loss of vascular endothelial (VE)-cadherin, an endothelial junctional protein. Dasatinib inhibited VEGF-induced phosphorylation of Src in human retinal microvascular endothelial cells (HRMECs). In vitro and in vivo vascular permeability assays showed that dasatinib blocked the VEGF-enhanced hyperpermeability of HRMECs and decreased VEGF-mediated retinal vascular leakage in mice. Immunofluorescent staining of VE-cadherin showed that dasatinib abolished the junctional disappearance of VE-cadherin in VEGF-treated HRMECs and murine retinal vasculature. In addition, we examined the protective effect of dasatinib against diabetes-induced retinal vascular leakage in streptozotocin-induced diabetic rats. An intravitreal injection of dasatinib substantially inhibited the development of hyperpermeable retinal vasculature. Our results indicate that dasatinib is a promising agent for the prevention and treatment of diabetes-induced retinal vascular leakage.Keywords
Funding Information
- National Research Foundation of Korea grant funded by the Korea government ((2015R1D1A1A02061724; 2015R1A2A1A15052509))
This publication has 24 references indexed in Scilit:
- Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathyJournal of Diabetes and its Complications, 2012
- VEGFR2 and Src Kinase Inhibitors Suppress Andes Virus-Induced Endothelial Cell PermeabilityJournal of Virology, 2011
- Dasatinib Is Preclinically Active against Src-Overexpressing Human Transitional Cell Carcinoma of the Urothelium with Activated Src SignalingMolecular Cancer Therapeutics, 2010
- The Control of Vascular Integrity by Endothelial Cell Junctions: Molecular Basis and Pathological ImplicationsDevelopmental Cell, 2009
- Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasisCell and tissue research, 2008
- Regulation of endothelial permeability by Src kinase signaling: Vascular leakage versus transcellular transport of drugs and macromoleculesChemico-Biological Interactions, 2008
- VEGF controls endothelial-cell permeability by promoting the β-arrestin-dependent endocytosis of VE-cadherinNature Cell Biology, 2006
- Tyrosine Phosphorylation of VE-cadherin Prevents Binding of p120- and β-Catenin and Maintains the Cellular Mesenchymal StateJournal of Biological Chemistry, 2005
- Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathyAmerican Journal of Ophthalmology, 2005
- Correlation of the Phosphorylation States of pp60c-src with Tyrosine Kinase Activity: The Intramolecular pY530−SH2 Complex Retains Significant Activity If Y419 Is PhosphorylatedBiochemistry, 1996